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ABSTRACT
OBJECTIVE: Identify and critically evaluate systematic reviews addressing the effectiveness 
of interventions to reduce the number of prescriptions of potentially inappropriate medication 
to older patients.
METHODS: This is an overview of systematic reviews. The studies were searched and 
selected from Medline, Cochrane Library, Embase, CINAHL, Virtual Health Library, and Web 
of Science databases, combining the terms aged, prescriptions, inappropriate prescribing and 
potentially inappropriate medication list with their entry terms and other related descriptors, 
published by June 2017. This study included systematic reviews with or without meta-analysis 
that addressed the effectiveness of any intervention or combined interventions to reduce the 
number of prescriptions of potentially inappropriate medications to older patients, without 
restriction in terms of design, language or date of publication of primary studies. AMSTAR – A 
MeaSurement Tool to Assess systematic Reviews – was used to evaluate the methodological 
quality of selected systematic reviews. Study selection and the methodological quality evaluation 
were performed by two independent evaluators, who resolved any divergence by consensus. 
The main findings were grouped into thematic categories, defined after a content analysis and 
discussed qualitatively as narrative synthesis.
RESULTS: This study analyzed 24 systematic reviews. In terms of study design and 
methodological quality evaluation, most were systematic reviews of randomized controlled 
clinical trials and studies of moderate quality, respectively. The interventions were analyzed 
in five thematic categories: medication review services, pharmaceutical interventions, 
computerized systems, educational interventions, and others. The interventions analyzed 
showed good results and most of them helped reduce the number of prescriptions of potentially 
inappropriate medication to older patients.
CONCLUSIONS: The systematic reviews included in this overview showed potential benefits of 
different interventions. However, it was not possible to determine the most effective intervention. 
Combined interventions are likely to provide better results than isolated interventions.
DESCRIPTORS: Aged. Health of the Elderly. Patient Medication Knowledge. Inappropriate 
Prescribing, prevention & control. Review. 
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INTRODUCTION
Among current global challenges, one trend is that world population ages rapidly, and this 
demographic transition will affect almost every aspect of society1. According to estimates, 
the number of people aged 60 and over will increase from 962 million in 2017 to 2.1 billion 
in 2050 and 3.1 billion in 2100a.
This population growth poses significant challenges for health systems, increasing the 
demand for health resources, including medication2. The greater the number of items 
used by a patient, the greater the chances of such patient being submitted to therapy with 
potentially inappropriate medication3.
Prescription of potentially inappropriate medication occurs when the risk of adverse 
events outweighs the clinical benefit. It also refers to overuse, prescription of multiple 
drugs with known interactions, incorrect indication or dose, and drug taken longer 
than necessary4,5.
Adverse events and drug interactions cause significant morbidity and mortality, 
especially in older patients as they present alterations in body composition and renal 
and hepatic functions6–8.
Prescription of potentially inappropriate medication to older patients has received special 
attention from health professionals, care providers, researchers, and health policymakers 
worldwide9. Therefore, this study aimed to identify and critically evaluate systematic 
reviews addressing the effectiveness of interventions to reduce prescriptions of potentially 
inappropriate medication to older patients.
METHODS
Study Design
This is an overview of systematic reviews addressing the effectiveness of interventions to 
reduce the number of prescriptions of potentially inappropriate medication to older patients.
Eligibility
The inclusion criteria of this overview were:
• Participants: older patients (≥65 years) who have received drug prescription.
• Interventions: the ones described in the selected studies aiming to reduce the number 
of prescriptions of potentially inappropriate medication to elderly patients.
• Comparators: usual care to elderly patients or comparison to different interventions.
• Outcomes: primary and secondary outcomes evaluated in the systematic reviews 
included in this study.
• Study types: systematic reviews with or without meta-analysis that addressed the 
effectiveness of any intervention or combination of interventions to reduce the number 
of prescriptions of potentially inappropriate drugs to elderly patients, without restriction 
in terms of design of primary studies.
Exclusion Criteria
This overview excluded reviews based on the following criteria: a) abstracts for conference 
papers and protocols of systematic reviews; b) reviews exclusively based on gray literature; 
c) studies focused on a specific clinical condition or related to a particular medication or 
therapeutic class; d) systematic reviews addressing exclusively under-use of medications 
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or interventions to improve treatment adherence; e) systematic reviews that have been 
updated, without loss of relevant information.
Search Method for Study Identification
The studies were searched and selected from Medline, Cochrane Library, Embase, 
CINAHL, Virtual Health Library, and Web of Science databases, combining the terms aged, 
prescriptions, inappropriate prescribing and potentially inappropriate medication list with 
their entry terms and other related descriptors without restriction in terms of study language 
or date of publication published by June 2017. Box 1 shows the full list of descriptors and 
Box 2 shows the search strategy in Medline database.
Box 2. Search strategy in Medline database (via PubMed).
Identification Search terms
#1 Elderly OR aged OR frail elderly 
#2 
Prescriptions OR prescription OR prescriptions, non-drug OR non-drug prescription OR non-drug prescriptions OR 
prescription, non-drug OR prescriptions, non drug OR prescriptions, nondrug OR nondrug prescription OR nondrug 
prescriptions OR prescription, nondrug OR drug prescriptions OR drug prescription OR drug prescribing OR prescribing, 
drug OR prescribing OR prescri* 
#3 
Inappropriate Prescribing OR Inappropriate Prescribings OR Prescribing, Inappropriate OR Prescribings, Inappropriate OR 
Inappropriate Prescriptions OR Inappropriate Prescription OR Prescription, Inappropriate OR Prescriptions, Inappropriate OR Over 
Prescribing OR Over Prescribings OR Prescribing, Over OR Prescribings, Over OR Potentially Inappropriate Medication List OR 
potentially inappropriate medications OR beers OR start OR stopp OR medication appropriateness index OR nurse* OR nursing 
OR pharmacist* OR pharmaceutical OR intervention* OR clinical decision making 
#4 Systematic[sb] 
#5 #1 AND #2 AND #3 AND #4 
Box 1. Descriptors used in database search.
MeSH terms
Aged Prescriptions Inappropriate prescribing Potentially inappropriate medication list
Entry terms
Elderly
Prescription
Prescriptions, non-drug
Non-drug prescription
Non-drug prescriptions
Prescription, non-drug
Prescriptions, non drug
Prescriptions, nondrug
Nondrug prescription
Nondrug prescriptions
Prescription, nondrug
Inappropriate prescribings
Prescribing, inappropriate
Prescribings, inappropriate
Inappropriate prescriptions
Inappropriate prescription
Prescription, inappropriate
Prescriptions, inappropriate
Over prescribing
Over prescribings
Prescribing, over
Prescribings, over
PIM List
PIM Lists
Potentially inappropriate medications
Inappropriate medication, potentially
Inappropriate medications, potentially
Medication, potentially inappropriate
Medications, potentially inappropriate
Potentially inappropriate medication
Beers criteria
Beers potentially inappropriate 
medications
De Beers criteria
Beers criteria, de
STOPP (Screening Tool of Older Person’s 
Potentially Inappropriate Prescriptions)
STOPP (Screening Tool of Older Person’s 
Potentially Inappropriate Prescriptions)
Screening Tool of Older Person’s Potentially 
Inappropriate Prescriptions
STOPP
STOPP START Criteria
Criteria, STOPP START
Criterias, STOPP START
START Criteria, STOPP
START Criterias, STOPP
STOPP START Criterias
Medication appropriateness index
Appropriateness index, medication
Appropriateness indices, medication
Index, medication appropriateness
Indices, medication appropriateness
Medication appropriateness indices
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Study Selection
First, the titles and abstracts of searched reviews were evaluated to identify the studies that 
met the eligibility criteria. Then, full texts were analyzed and the references were reviewed to 
identify further relevant studies. Both stages were performed by two independent reviewers, 
and the divergences were resolved by consensus.
Data Extraction
Information was extracted about study population, type of intervention, professionals 
involved in the intervention, comparative treatment, outcome measures, and design of the 
studies included in the systematic reviews. Complementary information about diseases, sites 
where the interventions were implemented, and the tools used to assess the prescription of 
potentially inappropriate medication was also extracted, when available.
Data extraction was performed by the first reviewer and the information obtained was 
subsequently checked by a second reviewer. The divergences were resolved by consensus.
Quality Assessment
A MeaSurement Tool to Assess systematic Reviews (AMSTAR) was used for the 
methodological quality evaluation of the selected systematic reviews10. This instrument 
was specifically designed to evaluate systematic reviews and includes 11 items with 
four possible answers each. Every question with affirmative answer receives score 1. The 
systematic reviews selected were assessed by independent reviewers, and the divergences 
were resolved by consensus.
Based on the consensus score, the systematic reviews were classified as three levels: low 
methodological quality (score 0 to 3), moderate methodological quality (score 4 to 7), and 
high methodological quality (score 8 to 11)11.
Data Analysis
The main results of the systematic reviews were grouped into thematic categories and 
discussed qualitatively as narrative synthesis. The method of content analysis was adopted 
to define the thematic categories12,13.
Extracted data were based on the results from each systematic review. Studies of multiple 
approaches were discussed under more than one thematic category. Discrepancies in the 
classification of interventions were resolved by consensus. The interventions identified 
and their results were described in narrative. Detailed information was extracted and 
systematized to discuss possible discrepant results of the interventions.
No meta-analyses or other quantitative analyses were performed because of the 
heterogeneity of the studies, considering their different designs, types of intervention, 
outcomes and measures.
RESULTS
Study Selection
In total, 1,850 studies were identified in the databases, and 302 duplicates were removed, resulting 
in 1,548 studies submitted to title and abstract screening. This initial screening removed 1,487 
studies that did not meet the selection criteria. Later, after fully reading 61 eligible studies, 37 
were excluded because they did not meet the inclusion criteria, resulting in 24 studies selected 
for this review. The flow diagram in Figure shows the study selection process.
Two systematic reviews from Cochrane14,15 retrieved in the search were subsequently 
updated. This overview included the two most recent studies16,17 only.
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Characteristics of Studies
Table 1 shows the main characteristics of the studies. In terms of design of primary studies 
included in the systematic reviews, most of them were randomized controlled clinical trials. 
The number of primary studies included in the systematic reviews varied from four to 116. 
These studies were conducted in different settings, including: primary care, community, 
hospitals, nursing homes, and long-term care facilities. Fifteen systematic reviews were 
published in 2014–2017.
Methodological Quality Assessment
The methodological quality assessment according to AMSTAR found most systematic 
reviews of moderate quality (n = 10). Six studies presented enough score to be considered 
of high methodological quality and eight were classified as low quality studies. The last 
column of Table 1 shows the scores attributed to each systematic review.
Figure. Flow diagram showing the selection process of systematic reviews about interventions to reduce 
the number of prescriptions of potentially inappropriate medications to older patients. 
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Table 1. Characteristics of studies included in this overview.
Author (year) Study design
Number of 
studies included
Interventions Setting
AMSTAR 
score
Alldred et al.16 (2016) Randomized controlled clinical trial 12
Educational Interventions
Medication review
Computerized systems
Long-term 
care unit
8/11
Castelino et al.19 (2009) Randomized controlled clinical trial 12
Pharmaceutical intervention
Medication review
Hospital 5/11
Cooper et al.2 (2015) Randomized controlled clinical trial 12
Pharmaceutical intervention
Medication review
Hospital 9/11
Forsetlund et al.5 (2011) Randomized controlled clinical trial 20
Educational Intervention
Medication review
Nursing home 7/11
Gutierrez Valencia et 
al.7 (2016)
Prospective studies (not necessarily controlled 
and randomized) with interventions
18
Pharmaceutical interventions
Educational Interventions
Computerized systems
Medication review
Hospital 7/11
Iankowitz et al.46 (2015)
Randomized controlled clinical trial, 
quasi-experimental study
5 Computerized systems Hospital 9/11
Johansson et al.27 
(2016)
Randomized controlled clinical trial, randomized 
controlled trial, non-randomized controlled 
clinical trial, cohort study, case-control study
25
Pharmaceutical interventions
Medication review
Hospital 3/11
Kaur et al.20 (2009)
Randomized controlled clinical trial, prospective 
study, cohort study, survey, retrospective and 
prospective case series
24
Pharmaceutical interventions
Educational Interventions
Computerized systems
Medication review
Other interventions
Hospital 6/11
Loganathan et al.28 
(2011)
Randomized controlled clinical trial and 
non-randomized controlled clinical trial
16
Pharmaceutical interventions
Educational Interventions
Computerized systems
Medication review
Nursing home 8/11
Loh et al.29 (2016) Randomized controlled clinical trial 25 Medication review Community 3/11
Maeda24 (2009)
Randomized controlled trials, controlled clinical 
trials
28 Medication review
Community
Hospital
Nursing home
5/11
Marasinghe45 (2015)
Randomized controlled clinical trial, cohort 
studies, retrospective and prospective studies
7 Computerized systems
Long-term 
care unit
6/11
Michelazzo et al.21 
(2017)
Case series 19
Pharmaceutical intervention
Educational Intervention
Medication review
Hospital
Community
Nursing home
3/11
Olaniyan et al.47 (2015)
Retrospective non-randomized study, 
Retrospective randomized study
68
Pharmaceutical intervention
Computerized systems
Primary care 9/11
Page et al.52 (2016) Randomized controlled clinical trial 116 Other interventions Hospital 10/11
Patterson et al.17 (2014)
Randomized controlled clinical trial, 
non-randomized controlled clinical trials, controlled 
before-after studies, interrupted time series
10
Pharmaceutical interventions
Computerized systems
Hospital 7/11
Riordan et al.22 (2016)
Randomized controlled clinical trial, 
quasi-randomized controlled clinical trial, controlled 
before-after studies, interrupted time series
5
Pharmaceutical interventions
Medication review
Primary care 3/11
Rollason e Vogt25 (2003) Randomized controlled clinical trial 14
Pharmaceutical interventions
Medication review
Hospital 3/11
Shade et al.48 (2014)
Randomized controlled clinical trial and 
non-randomized clinical trial
67 Computerized systems Community 7/11
Thiruchelvam et al.23 
(2017)
Randomized controlled clinical trial and 
observational studies
22 Medication review Hospital 5/11
Tjia et al.33 (2013)
Randomized controlled clinical trial and 
non-randomized clinical trial, before-after 
studies, case series
36 Medication review
Hospital
Nursing home
3/11
Verrue et al.30 (2009)
Controlled trials (randomized or 
non-randomized)
8
Pharmaceutical interventions
Medication review
Nursing home 3/11
Walsh et al.35 (2016)
Controlled trials (randomized or 
non-randomized)
4
Pharmaceutical interventions
Medication review
Hospital 7/11
Yourman et al.50 (2008) Randomized controlled clinical trial 10 Computerized systems Hospital 3/11
AMSTAR: A MeaSurement Tool to Assess systematic Reviews
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Synthesis of Interventions Grouped into Thematic Categories
The interventions identified in selected systematic reviews were grouped into five thematic 
categories: medication review services (n = 16), pharmaceutical interventions (n = 10), 
computerized systems (n = 10), educational interventions (n = 8), and other interventions 
(n = 2).
Medication review services were not analyzed in the category of pharmaceutical 
interventions because, although they may be conducted by pharmacists, they often include 
other health professionals.
Table 2 shows the thematic categories addressed in each systematic review included in 
this study.
Medication Review Services
Medication review includes many interventions that can be performed by prescribers 
(self-review) or other health professionals (usually physicians, pharmacists, and nurses), 
alone or combined with others, that provide prescribers with recommendations to improve 
the quality of prescription and increase drug use safety18.
Although the descriptions of medication reviews varied in the studies analyzed, the process 
generally involved a systematic assessment of the patient’s pharmacotherapeutic needs and 
prescribed drugs, followed by recommendations to optimize the dosage. Promising results 
were observed in interventions involving pharmacists, with the authors emphasizing the 
Table 2. Thematic categories addressed in the systematic reviews about interventions to reduce the number of prescriptions of inappropriate 
medications to older patients evaluated in this overview.
Author (year)
Interventions
Medication review 
services
Pharmaceutical 
interventions
Computerized 
systems
Educational 
interventions
Other interventions
Alldred et al.16 (2016) X X X
Castelino et al.19 (2009) X X
Cooper et al.2 (2015) X X
Forsetlund et al.5 (2011) X X
Gutierrez Valencia et al.7 (2016) X X X
Iankowitz et al.46 (2015) X
Johansson et al.27 (2016) X
Kaur et al.20 (2009) X X X X X
Loganathan et al.28 (2011) X X X X
Loh et al.29 (2016) X
Maeda24 (2009) X
Marasinghe45 (2015) X
Michelazzo et al.21 (2017) X X X
Olaniyan et al.47 (2015) X
Page et al.52 (2016) X X
Patterson et al.17 (2014) X X
Riordan et al.22 (2016) X X
Rollason e Vogt25 (2003) X X
Shade et al.48 (2014) X X
Thiruchelvam et al.23 (2017) X
Tjia et al.33 (2013) X
Verrue et al.30 (2009) X X
Walsh et al.35 (2016) X
Yourman et al.50 (2008) X
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importance of training these professionals on tools to identify inappropriate medications 
for older patients19.
Medication review with a clinical pharmacist may have a positive influence on the use of 
medicines. These interventions, either alone or combined with others, can reduce the use 
of potentially inappropriate medications by older patients in different settings2,5,7,20–25.
On the other hand, Holland et al.26 evaluated the impact of medication review on hospital 
admissions and mortality and found no positive effect.
The studies used different methods for medication review, whose methodology is a key issue 
in interventions, and it is not clear which would be the most appropriate27. The selection of 
outcomes to be measured in primary studies has also influenced the results28.
Many studies do not mention whether or not the recommended changes in prescription 
after the medication review were accepted by the prescriber. According to the authors, this 
is a critical parameter in medication review evaluation, since it describes actual changes 
in patient treatment as a result of the intervention29,30. These rates varied from 39.0%31 to 
91.6%32, with possible low acceptance justified by the indirect contact of the pharmacist 
with the general practitioner, demonstrating the importance of communication in the 
multidisciplinary health team. The heterogeneity in study design and the quality of studies 
are obstacles to conclude whether medication reviews by pharmacists are more effective 
than interdisciplinary interventions33.
Pharmaceutical Intervention
It refers to the clinical practice of pharmacists, often integrated with physicians, nurses and 
other members of the health team, to solve or prevent problems that interfere or may interfere 
in the pharmacotherapy, which is part of the care process. The main objective of this activity 
is the prevention of errors in drug prescription, dispensing and administration, with a critical 
role in promoting the rational use of medication by ensuring proper pharmacotherapy with 
safe therapeutic results and minimizing unfavorable outcomes34.
Pharmaceutical care seems to improve prescriptions to older patients taking different 
medications at the same time (polypharmacy), especially when a multidisciplinary element 
is included in care17. The practice of pharmacists has been associated with benefits in 
different contexts, including primary care22, hospitals28,35, and nursing homes28,30. However, 
the role of a pharmacist in a multidisciplinary team needs to be more valued to help achieve 
the expected results22.
Castelino et al.19 highlighted the importance of training pharmacists on validated tools 
to identify inappropriate medications. They also argued that the quality of a prescription 
can improve when these professionals assume a more active role in this process, since 
intervention studies generally focus on identifying failures after prescription.
On the other hand, Cooper et al.2 found no evidence of benefit from pharmaceutical 
interventions on adverse events and admissions. Inadequate selection of outcome measures 
may have influenced the evaluation of efficacy of such interventions, whose therapeutic 
adequacy has been analyzed more often than other relevant health outcomes21,28.
Computerized Systems
Computerized systems allow electronic prescription and records about the medications 
taken by every patient; besides, they issue risk alerts and provide information about drug 
interactions. These systems are often used at two different levels: when making decisions 
and issuing alerts to pharmacies when dispensing drugs20,36–44.
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Information and communications technologies are increasingly used to optimize 
prescriptions in different settings16. Most studies have demonstrated the effectiveness of 
computerized systems7,20,28,45, including meta-analysis46.
Collaborative implementation of computerized systems and other interventions can 
optimize the safety of medication use in primary care and improve health outcomes47. 
Patterson et al.17 also highlighted a study36 whose results were positive and showed that most 
pharmaceutical interventions involved a multidisciplinary component and interventions 
through computerized systems.
Although studies indicate a significant reduction of potentially inappropriate drug 
prescriptions, computerized systems may not provide a full picture of medication use by 
older patients, since other drugs may be purchased at pharmacies not participating in the 
intervention or as over-the-counter medicines48. Gurwitz et al.49 also pointed out that the 
high number of alerts in a system can cause prescribers to ignore them, with a negative 
impact on the prescriptions.
Successful interventions with computerized systems should be tested and improved 
in different settings to enhance patient safety and minimize adverse effects. Regular 
medication review and timely interventions in prescriptions are essential in clinical practice 
to address the increasing challenges involving prescriptions to older patients50.
Educational Interventions
Educational interventions can be conducted in different ways, including educational 
sessions for health professionals aiming to reduce drug use; distribution of educational 
materials; training to expand the knowledge and skills of patients, caregivers, and health 
professionals; educational programs for prescribers or consumers; and patient education 
to optimize polypharmacy17,51,52.
Educational interventions may reduce inappropriate drug prescription5,20,48 and 
hospitalization period53, either alone or combined with other interventions7.
Loganathan et al.28 analyzed six studies54–59 that adopted strategies of educational 
intervention, resulting in improvements in prescriptions. These interventions included face-
to-face academic detailing, interaction between the prescriber and a group of specialists, 
workshops for nurses, and family education.
However, educational interventions have been studied more in terms of changes in therapy than 
for other outcomes related to the quality of life of patients, costs and use of health services21.
Other Interventions
Two systematic reviews addressed other interventions to reduce the number of prescriptions 
of potentially inappropriate medications to older patients, including: geriatric medicine 
services20, regulatory interventions20, and deprescription52.
In a study conducted by Kaur et al.20, all interventions involving geriatric medicine 
services resulted in improvements for patients. The authors also highlighted two studies 
on regulatory interventions that reduced the number of potentially inappropriate drug 
prescription: one in which pharmacy service provision became mandatory in nursing 
homes in Canada60, and one that assessed the impact of restrictive measures adopted in 
the Australian form Pharmaceutical Benefits Scheme (PBS), which lists prescription drugs 
subsidized by the government61.
Page et al.52 presented data about deprescription interventions aiming to reduce 
polypharmacy and extend longevity. Although the authors state further studies are 
required, their findings suggest that individualized interventions help reduce inappropriate 
polypharmacy and seem to be safe and feasible.
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DISCUSSION
Main Findings
This overview of systematic reviews summarizes evidence of interventions to reduce 
the number of prescriptions of potentially inappropriate medications to older patients, 
identifying knowledge gaps and providing insight for policy making and future studies.
Medication review prevailed among the types of intervention in this overview. Most 
studies support the benefits of this intervention, especially when using validated tools. 
It has produced better results when associated with other interventions2,5,16,20,22. On the 
other hand, choice of outcome measures28, study design33, and methodological quality33 
have often been obstacles when assessing the efficacy of this intervention.
The practice of pharmacists to reduce the number of prescriptions of potentially 
inappropriate medications to older patients is also highlighted in the literature. In this 
type of intervention, pharmacists can act with autonomy to change the prescription, or act 
passively, identifying problems related to medications and recommending changes to the 
prescriber, who makes the final decision62. The practice of pharmacists seems to improve 
prescription in different settings (hospitals, primary care, and nursing homes), particularly 
when inserted in multidisciplinary teams.
The use of computerized systems presented the best evidence of benefit in selected studies. 
These resources have been increasingly used in different scenarios, supporting either clinical 
decision making or the pharmacotherapeutic analysis in drug dispensing16,20,45,46,50.
Educational interventions can be designed for prescribers, other health professionals, 
patients or caregivers. Whether alone or combined with other interventions, they have been 
effective in reducing inappropriate use of medications5,20,28.
Regulatory policies that have produced positive results include the potential benefits of 
eliminating subsidies from potentially inappropriate medications to influence prescribing61 
and making pharmacy services mandatory in nursing homes in Canada60.
Geriatric medicine services20 and deprescription52 have also resulted in improvements 
for patients.
Strengths and Limitations
One of the reasons for an overview of systematic reviews was to identify different 
interventions already implemented and evaluated in clinical practice and check which 
ones present the best evidence of benefit to promote the rational use of medications among 
older patients.
The strengths of this study include: description of interventions to reduce the number 
of prescriptions of potentially inappropriate medications to older patients, based on the 
evidence available; comprehensive search structured according to the PICOS (patient, 
intervention, comparison, outcomes and study type) method; methodological quality 
assessment of the studies; and no restrictions regarding language or date of publication.
The quality of systematic reviews, predominantly moderate, must be confirmed by further 
studies designed with more methodological rigor. It means that although each type of 
intervention reported relevant results, it was not possible to reach definitive conclusions 
about the most effective intervention to reduce the number of prescriptions of potentially 
inappropriate medications to older patients.
In addition, overviews of systematic reviews are subject to important limitations, especially 
when addressing complex issues and heterogeneous outcomes. When systematizing the 
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results of almost 600 primary studies, particularities of individual studies may have been 
lost or neglected by the authors of the respective systematic reviews.
Implications for Practice
Evidence supports that the use of computerized systems reduces the prescription and 
dispensing of inappropriate drugs to older patients. Medication review, either by health 
professionals alone or in a multidisciplinary team, has presented promising results. However, 
the acceptance of recommendations by prescribers plays a critical role in the achievement of 
results, so there is no consensus on which is the best methodology. Interventions conducted 
by pharmacists may also improve drug prescription to older patients. It stresses the trend of 
pharmaceutical care implementation and values the clinical role of pharmacists integrated 
with other health professionals.
A combination of interventions was supported by the evidence of educational interventions5,7 
and in the evaluation of the effectiveness of computerized systems47,50 and medication 
review services2,5,16,20,22.
Ideally, interventions should have been evaluated using clinically relevant outcomes, 
such as mortality, quality of life, or utilization of health services. But these outcomes 
were not evaluated in most primary studies included in the systematic reviews. Then, the 
interventions described can improve the prescription and enhance safety in the use of 
medications, but cannot confirm the clinical benefits achieved.
Implications for Research and Health Policies
A detailed description of the interventions, the settings where they were studied, the 
implementation strategies, and the results achieved is critical to reinforce the evidence and 
support the selection and implementation of the best interventions and their reproduction 
in different contexts2,17. Also important, the cost of interventions should be compared to 
the economic impact of potentially inappropriate drug prescriptions to sensitize managers 
and policy makers.
Patient preferences, beliefs and behaviors may also be considered, as well as economic 
assessments and other aspects of health policies. Qualitative studies involving health 
professionals and patients can provide important information about obstacles for the 
implementation or acceptance of an intervention27. Interviews with prescribers can help 
understand their reasons for not accepting recommendations and alerts from computerized 
systems that support drug prescription.
Instead of evaluating the reduction in the number of potentially inappropriate drug 
prescriptions, a trend is observed towards the assessment of whether polypharmacy can 
be considered appropriate (when drugs were prescribed and used according to the best 
evidence) or inappropriate (when inappropriately prescribed or the intended benefits have 
not been achieved)17.
Future studies should ensure greater methodological rigor in the evaluation of interventions 
to reduce the number of potentially inappropriate drug prescription to older patients. 
Further studies are required which should investigate the effectiveness of individual and 
combined interventions. Studies comparing different interventions can also establish the 
real value of each intervention.
CONCLUSIONS
The systematic reviews included in this overview showed potential benefits from different 
interventions in reducing the number of prescriptions of potentially inappropriate 
medications to older patients. The results expected from each intervention were discussed in 
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this overview, and although it was not possible to determine which one is the most effective, 
combined interventions are likely to achieve better results than isolated interventions.
Knowledge gaps reveal relevant topics for future studies to be conducted with the higher 
methodological rigor.
In order to increase the safety of medication use by older patients, organizational and 
structural measures can be planned and implemented in health services, such as: 
computerized systems to support drug prescription and dispensing, training on the use of 
validated tools for the detection of potentially inappropriate drugs, procedures and explicit 
routines for medication review, continuing education for health professionals, and geriatric 
medicine services.
It should be noted that the deployment of any intervention can become a reality with 
the involvement of all stakeholders: policy makers, administrators, health professionals, 
patients, and caregivers.
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